Cancer Research The Future of Cancer Research: Science and Patient Impact AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J.-S.
Right arrow Articles by Waldman, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J.-S.
Right arrow Articles by Waldman, T.
[Cancer Research 62, 2744-2748, May 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Oncogenic ß-Catenin Is Required for Bone Morphogenetic Protein 4 Expression in Human Cancer Cells1

Jung-Sik Kim, Heather Crooks, Tatiana Dracheva, Tagvor G. Nishanian, Baljit Singh, Jin Jen and Todd Waldman2

Departments of Oncology [J-S. K., H. C., T. G. N., B. S., T. W.], Pathology [B. S.], and Tumor Biology Training Program [T. G. N.], Lombardi Cancer Center, Georgetown University School of Medicine, Washington, DC 20007, and Laboratory of Population Genetics, Center for Cancer Research [T. D., J. J.], National Cancer Institute, Bethesda, Maryland 20892

Somatic cell gene targeting was used to create an isogenic set of human coloncancer cells that differs only in the presence or absence of their endogenous activated ß-catenin oncogene. Affymetrix Genechip expression profiling of parental cells and gene-targeted derivatives identified numerous novel genes whose expression was dependent on the presence of oncogenic ß-catenin. The transforming growth factor-ß family member bone morphogenetic protein 4 (BMP4), whose receptor is mutated in a rare inherited gastrointestinal cancer predisposition syndrome, was the most highly differentially expressed gene. Additional experiments revealed that the oncogenic allele of ß-catenin specifically is absolutely required for BMP4 expression and secretion by human cancer cells and that BMP4 is overexpressed and secreted by human colon cancer cells with mutant adenomatous polyposis coli genes. These data identify the presence of regulatory interactions between the Wnt and BMP signaling pathways in cancer pathogenesis, providing an intriguing connection between the sporadic and inherited forms of a common human malignancy.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
J. Dai, C. L. Hall, J. Escara-Wilke, A. Mizokami, J. M. Keller, and E. T. Keller
Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
Cancer Res., July 15, 2008; 68(14): 5785 - 5794.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. J. Fattah, N. F. Lichter, K. R. Fattah, S. Oh, and E. A. Hendrickson
Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells
PNAS, June 24, 2008; 105(25): 8703 - 8708.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. Madoz-Gurpide, P. Lopez-Serra, J. L. Martinez-Torrecuadrada, L. Sanchez, L. Lombardia, and J. I. Casal
Proteomics-based Validation of Genomic Data: Applications in Colorectal Cancer Diagnosis
Mol. Cell. Proteomics, August 1, 2006; 5(8): 1471 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. Katayama, K. Ashizawa, T. Fukuhara, M. Hiroyasu, Y. Tsuzuki, H. Tatemoto, T. Nakada, and K. Nagai
Differential Expression Patterns of Wnt and {beta}-Catenin/TCF Target Genes in the Uterus of Immature Female Rats Exposed to 17{alpha}-Ethynyl Estradiol
Toxicol. Sci., June 1, 2006; 91(2): 419 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
O. Topaloglu, P. J. Hurley, O. Yildirim, C. I. Civin, and F. Bunz
Improved methods for the generation of human gene knockout and knockin cell lines
Nucleic Acids Res., October 7, 2005; 33(18): e158 - e158.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
K Nosho, H Yamamoto, M Mikami, T Takahashi, Y Adachi, T Endo, K Hirata, K Imai, and Y Shinomura
Laterally spreading tumour in which interstitial deletion of {beta}-catenin exon 3 was detected
Gut, October 1, 2005; 54(10): 1504 - 1505.
[Full Text] [PDF]

Home page
 GENES CELLSHome page
M. Kasai, K. Satoh, and T. Akiyama
Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs
Genes Cells, August 1, 2005; 10(8): 777 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Hibbs, K. M. Skubitz, S. E. Pambuccian, R. C. Casey, K. M. Burleson, T. R. Oegema Jr, J. J. Thiele, S. M. Grindle, R. L. Bliss, and A. P.N. Skubitz
Differential Gene Expression in Ovarian Carcinoma: Identification of Potential Biomarkers
Am. J. Pathol., August 1, 2004; 165(2): 397 - 414.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. Hussein, E. K. Duff, and C. Sirard
Smad4 and {beta}-Catenin Co-activators Functionally Interact with Lymphoid-enhancing Factor to Regulate Graded Expression of Msx2
J. Biol. Chem., December 5, 2003; 278(49): 48805 - 48814.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Ray, R. Cabal-Manzano, A. R. Moser, T. Waldman, L. M. Zipper, A. Aigner, S. W. Byers, A. T. Riegel, and A. Wellstein
Up-Regulation of Fibroblast Growth Factor-Binding Protein, by {beta}-Catenin during Colon Carcinogenesis
Cancer Res., December 1, 2003; 63(23): 8085 - 8089.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Su, S. Ishikawa, M. Kojima, and B. Liu
Eradication of pathogenic {beta}-catenin by Skp1/Cullin/F box ubiquitination machinery
PNAS, October 28, 2003; 100(22): 12729 - 12734.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Wang, B. Vogelstein, and K. W. Kinzler
Phosphorylation of {beta}-Catenin at S33, S37, or T41 Can Occur in the Absence of Phosphorylation at T45 in Colon Cancer Cells
Cancer Res., September 1, 2003; 63(17): 5234 - 5235.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Xie, X. Zeng, T. Waldman, and R. I. Glazer
Transformation of Mammary Epithelial Cells by 3-Phosphoinositide- dependent Protein Kinase-1 Activates {beta}-Catenin and c-Myc, and Down-Regulates Caveolin-1
Cancer Res., September 1, 2003; 63(17): 5370 - 5375.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. R. Schwartz, R. Wu, S. L. R. Kardia, A. M. Levin, C.-C. Huang, K. A. Shedden, R. Kuick, D. E. Misek, S. M. Hanash, J. M. G. Taylor, et al.
Novel Candidate Targets of {beta}-Catenin/T-cell Factor Signaling Identified by Gene Expression Profiling of Ovarian Endometrioid Adenocarcinomas
Cancer Res., June 1, 2003; 63(11): 2913 - 2922.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J.-S. Kim, H. Crooks, A. Foxworth, and T. Waldman
Proof-of-Principle: Oncogenic {beta}-Catenin Is a Valid Molecular Target for the Development of Pharmacological Inhibitors
Mol. Cancer Ther., December 1, 2002; 1(14): 1355 - 1359.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.